Table 1.
Efficacy of Clopidogrel‐Aspirin Regimen for TIA and Minor Stroke
| Model Input | Aspirin‐Alone Regimen | Clopidogrel‐Aspirin Regimen | Reference |
|---|---|---|---|
| Proportion of patients after 90 days | CHANCE trial database | ||
| Minor or no disability (mRS 0 to 2) | 0.9233 | 0.9376 | |
| Moderate disability (mRS 3 to 4) | 0.0670 | 0.0527 | |
| Severe disability (mRS 5) | 0.0058 | 0.0058 | |
| Death (mRS 6) | 0.0039 | 0.0039 | |
| 90‐day event risks | |||
| Recurrent stroke | 0.1172 | 0.0820 | |
| Proportion of ICH | 0.0264 | 0.0377 | |
| Major ECH | 0.0066 | 0.0108 | |
| MI | 0.0008 | 0.0012 |
TIA indicates transient ischemic attack; CHANCE, Clopidogrel in High‐risk patients with Acute Non‐disabling Cerebrovascular Events Trial; mRS, modified Rankin Score; ICH, intracerebral hemorrhage; ECH, extracranial hemorrhage; MI, myocardial infarction.